IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10632093 B1

PDFFull Text
Date of Patent:
Apr. 28, 2020

Filed:

Oct. 24, 2016

Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients

Applicant:

N.v. Nutricia, Zoetermeer, NL;

Inventors:

Mattheus Cornelis De Wilde, Utrecht, NL;

Danielle Stefanie Counotte, Utrecht, NL;

Assignee:

N.V. NUTRICIA, Zoetermeer, NL;

Attorneys:

Gilberto M. Villacorta

Sunit Talapatra

Foley & Lardner LLP

Primary Examiner:

Blessing M Fubara

Int. Cl.
CPC ...
A61K 31/202 (2006.01); A61K 31/355 (2006.01); A61K 31/7072 (2006.01); A61K 31/714 (2006.01); A61K 33/04 (2006.01); A23L 33/15 (2016.01); A23L 33/175 (2016.01); A23L 33/12 (2016.01); A61K 31/593 (2006.01); A61K 31/4415 (2006.01); A61K 31/592 (2006.01); A61K 31/7068 (2006.01); A23L 33/115 (2016.01); A61K 31/4172 (2006.01); A61K 45/06 (2006.01); A61K 31/525 (2006.01); A61K 31/198 (2006.01); A61K 31/341 (2006.01); A61K 31/122 (2006.01); A61K 31/14 (2006.01); A61K 31/375 (2006.01); A61K 31/455 (2006.01); A61K 31/59 (2006.01); A61K 31/675 (2006.01); A61K 38/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/202 (2013.01); A23L 33/115 (2016.08); A23L 33/12 (2016.08); A23L 33/15 (2016.08); A23L 33/175 (2016.08); A61K 31/122 (2013.01); A61K 31/14 (2013.01); A61K 31/198 (2013.01); A61K 31/341 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/4172 (2013.01); A61K 31/4415 (2013.01); A61K 31/455 (2013.01); A61K 31/525 (2013.01); A61K 31/59 (2013.01); A61K 31/592 (2013.01); A61K 31/593 (2013.01); A61K 31/675 (2013.01); A61K 31/7068 (2013.01); A61K 31/7072 (2013.01); A61K 31/714 (2013.01); A61K 33/04 (2013.01); A61K 38/02 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01); A61K 2300/00 (2013.01);
Abstract

The invention pertains to the use of a composition in the manufacture of a product or method for therapeutically improving, promoting, restoring or maintaining recognition and/or working memory in a subject suffering from PKU and/or in a subject suffering from or at increased risk of impaired recognition and/or working memory associated with PKU, said composition comprising therapeutic amounts of: (i) at least one ω-3 polyunsaturated fatty acid (LCPUFA) selected from the group consisting of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and docosapentaenoic acid (DPA); (ii) choline, a choline salt and/or choline ester; and (iii) at least one B vitamin selected from the group consisting of vitamin B6, vitamin B12 and vitamin B9, including functional equivalents thereof, preferably vitamin B6 and/or vitamin B12, and functional equivalents thereof. The invention also pertains to a composition for use in such use or method.

Find Patent Forward Citations

Loading…